<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>Golden Horseshoe Biosciences Network  RSS Feed</title><link>http://www.ghbn.org/</link><description>Golden Horseshoe Biosciences Network  RSS Feed</description><language>en-US</language><item><category>News Feed</category><title>e7GPI - GPI Connect</title><link>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038036</link><description>Guelph Partnership for Innovation – “Connecting technology, money and people in Guelph, Canada”.
This will be of interest to newly forming or expanding companies, and will be surrounded by a “trade show” of key funding partners in Canada’s commercia</description><guid>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038036</guid><pubDate>Wed, 10 Mar 2010 08:00:00 EST</pubDate></item><item><category>News Feed</category><title>Virus can attack prostate cancer</title><link>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038035</link><description>Researchers in Alberta have successfully tested a new viral approach to treating prostate cancer in a small number of men.

The study was published in Tuesday's online issue Cancer Research, a journal of the American Association for Cancer Research</description><guid>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038035</guid><pubDate>Wed, 10 Mar 2010 08:00:00 EST</pubDate></item><item><category>News Feed</category><title>The "Clean 15" Canadian cleantech competition launched in Canadian Business Journal</title><link>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038037</link><description>The Clean 15 Series announced that it will collaborate with Canadian Business Journal and its strategic partners Yet2.com, Fogler, Rubinoff LLP and OCETA to launch the second “Clean 15” Canadian clean technology competition.  The “Clean 15” cleantech</description><guid>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038037</guid><pubDate>Wed, 10 Mar 2010 08:00:00 EST</pubDate></item><item><category>News Feed</category><title>Genetic cause discovered for rare bleeding disorder</title><link>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038028</link><description>For some Canadians, a cut from dental work or surgery can cause days or more of bleeding. Although they are not hemophiliacs, for some an ordinary bruise can balloon into the size of an orange. For others, knees, elbows and ankles are crippled when b</description><guid>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038028</guid><pubDate>Fri, 05 Mar 2010 08:00:00 EST</pubDate></item><item><category>News Feed</category><title>Cell-based Viral Vaccines: FDA Issues Final Guidance
</title><link>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038026</link><description>To boost development of cell-based viral vaccines FDA issued final guidance. Today’s guidance outlines the best practices using current and emerging science to safely expand the types of cells that may be used to produce vaccines.</description><guid>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038026</guid><pubDate>Thu, 04 Mar 2010 08:00:00 EST</pubDate></item><item><category>News Feed</category><title>Cool Climate Oenology &amp; Viticulture Institute</title><link>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038025</link><description>Niagara's own Jennifer Wilhelm from Niagara College was recognized in the Education category. And the promoter-at-large award, a new category, was given to Ken Burford, President of the Ontario Wine Society, who has been instrumental in promoting VQA</description><guid>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038025</guid><pubDate>Thu, 04 Mar 2010 08:00:00 EST</pubDate></item><item><category>News Feed</category><title>YORKBiotech Announces Winners of Sanofi Pasteur Healthcare &amp; Biotechnology Venture Challenge</title><link>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038023</link><description>Toronto (March 1, 2010) -The Sanofi Pasteur Healthcare and Biotechnology Venture Challenge (HBVC) 2009 first prize went to Sono Pharmaceuticals Inc for Immuno-SDT for Treatment of Cancer. The team comprised of scientific entrepreneur Dr. Arjen Bogaar</description><guid>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038023</guid><pubDate>Thu, 04 Mar 2010 08:00:00 EST</pubDate></item><item><category>News Feed</category><title>Eden Park scores $2M to bring LED alternative to market</title><link>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038020</link><description>Eden Park Illumination has officially entered the efficient lighting fray, scoring $2 million in new venture capital, and a $750,000 grant from the U.S. Air Force, according to Dow Jones Clean Technology Insight. It is pitching a microplasma lighting</description><guid>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038020</guid><pubDate>Mon, 01 Mar 2010 08:00:00 EST</pubDate></item><item><category>News Feed</category><title>'New era' in health policy</title><link>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038017</link><description>The doctor shortage, health budgets, and the number of medical radiation technologists and pharmacists needed in the province of Ontario are examples of some of the projects Arthur Sweetman will tackle.</description><guid>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038017</guid><pubDate>Mon, 01 Mar 2010 08:00:00 EST</pubDate></item><item><category>News Feed</category><title>MRI Cleantech asset map</title><link>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038016</link><description>MaRS and OCETA worked with MRI to complete a Cleantech asset map for Ontario. It is finally complete and officially launched today at the Cleantech Forum conference in San Francisco.</description><guid>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038016</guid><pubDate>Fri, 26 Feb 2010 08:00:00 EST</pubDate></item><item><category>News Feed</category><title>Government of Canada Invests in New Strategic Research Networks</title><link>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038001</link><description>More then ten new research networks have been created through the Canadian Government. </description><guid>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038001</guid><pubDate>Thu, 25 Feb 2010 08:00:00 EST</pubDate></item><item><category>News Feed</category><title>Brock research café focuses on bringing discoveries to market</title><link>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038000</link><description>New discoveries, whether the development of new drugs or the design of new techniques and inventions for efficiencies in industry and business, follow a circuitous route before we find them on the pharmacy shelf or in workplace activities.</description><guid>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1038000</guid><pubDate>Thu, 25 Feb 2010 08:00:00 EST</pubDate></item><item><category>News Feed</category><title>Sustainable Development Technology Canada Announces Latest Call for Clean Technology Funding Applications </title><link>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1037999</link><description>Ottawa, Ontario, February 24, 2010 – Sustainable Development Technology Canada (SDTC) is calling on entrepreneurs and technology developers across Canada to submit Statements of Interests to the SD Tech Fund™, as SDTC opens its 17th round of funding.</description><guid>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1037999</guid><pubDate>Thu, 25 Feb 2010 08:00:00 EST</pubDate></item><item><category>News Feed</category><title>Brock grads win big at Cuvée wine awards</title><link>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1037991</link><description>Graduates of Brock University’s Oenology and Viticulture program won half of the coveted Cuvée gold awards handed out at the 22nd annual Cuvée Gala on Feb. 19 at the Niagara Fallsview Casino. </description><guid>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1037991</guid><pubDate>Wed, 24 Feb 2010 08:00:00 EST</pubDate></item><item><category>News Feed</category><title>Students compete in sixth season of MARS Apprentice</title><link>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1037990</link><description>The innovative marketing competition gives students the chance to apply classroom knowledge to real-world situations. Two teams of undergraduate students go head-to-head in intense competition, solving business challenges provided by industry sponsor</description><guid>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1037990</guid><pubDate>Wed, 24 Feb 2010 08:00:00 EST</pubDate></item><item><category>News Feed</category><title>High blood pressure: Canada's crisis 

</title><link>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1037989</link><description>High blood pressure, also known as hypertension, is becoming a national crisis, particularly among younger Canadians, say health authorities. That's because obesity rates, physical inactivity and diabetes are on the rise — all known risk factors for </description><guid>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1037989</guid><pubDate>Tue, 23 Feb 2010 08:00:00 EST</pubDate></item><item><category>News Feed</category><title>HIV vaccine facility won't be built</title><link>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1037988</link><description>Winnipeg HIV vaccine manufacturing facility will not be built for numerous reasons including local politics.</description><guid>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1037988</guid><pubDate>Mon, 22 Feb 2010 08:00:00 EST</pubDate></item><item><category>News Feed</category><title>McMaster Imaging Workshop, March 26
</title><link>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1037985</link><description>
Advances in imaging technology are expanding knowledge in a wide variety of disciplines. The imaging research underway at McMaster covers topics in the neurosciences, engineering, physics and a variety of other disciplines. The results of this rese</description><guid>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1037985</guid><pubDate>Fri, 19 Feb 2010 08:00:00 EST</pubDate></item><item><category>News Feed</category><title>Affinity Biologicals: ELISA Promotion</title><link>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1037984</link><description>For a limited time, when you order one or more paired antibody set for ELISA, we will also send you one each of the accessory products VisuLize™ Buffer Pak and VisuCal™Antigen Calibrator Plasma at no charge.</description><guid>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1037984</guid><pubDate>Thu, 18 Feb 2010 08:00:00 EST</pubDate></item><item><category>News Feed</category><title>McMaster-led study finds short-term radiation therapy successful against breast cancer</title><link>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1037982</link><description>An intense three-week course of radiation therapy is just as effective as the standard five-week regimen for women with early-stage breast cancer. </description><guid>http://www.ghbn.org/detail.aspx?menu=37&amp;app=181&amp;cat1=543&amp;tp=12&amp;lk=g&amp;dt=1037982</guid><pubDate>Tue, 16 Feb 2010 08:00:00 EST</pubDate></item></channel></rss>
